Last reviewed · How we verify
NCT06585267: SYNC01- P4
Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis
trial in Complete Questionnaires Following TKR Surgery in 167 participants. Participants enrolled and being followed up; not accepting new ones.
9 September 2025
Quick facts
| Lead sponsor | Invibio Ltd |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 167 |
| Start date | 7 October 2024 |
| Primary completion | 9 September 2025 |
| Estimated completion | 14 April 2026 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Complete Questionnaires Following TKR Surgery — all drugs for Complete Questionnaires Following TKR Surgery →
Sponsor
Invibio Ltd
Who can join
18 and older, any sex, with Complete Questionnaires Following TKR Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Development of a new Patient Reported Outcome Measure (PROM) to assess patient's emotional wellbeing, and perceptions of Total Knee Replacement surgery for the treatment of knee arthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06585267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Invibio Ltd trials
Trials by the same sponsor.
- NCT05692687 — A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone · completed
- NCT05597046 — Qualitative Interviews With Healthcare Professionals · completed
- NCT04416321 — A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced. · NA · completed
- NCT03928041 — A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06585267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Invibio Ltd
- Last refreshed: 1 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06585267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing